PepsiCo Faces Deadline on Elliott-Inspired Targets Amid GLP-1 Threat
PepsiCo is under pressure to meet growth and margin targets set after Elliott Investment Management's stake, as GLP-1 drugs pose a growing threat to its snack business.
PepsiCo is under pressure to meet growth and margin targets set after Elliott Investment Management's stake, as GLP-1 drugs pose a growing threat to its snack business.